Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Down 27.9% in January

Nexalin Technology, Inc. (NASDAQ:NXL) saw a significant decrease in short interest in January. As of January 15th, there was short interest totaling 32,516 shares, a decrease of 27.9% from the December 31st total of 45,120 shares. Based on an average daily trading volume, of 118,816 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.2% of the company’s shares are sold short. Currently, 0.2% of the company’s shares are sold short. Based on an average daily trading volume, of 118,816 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Investors Weigh In On Nexalin Technology

An institutional investor recently bought a new position in Nexalin Technology stock. Susquehanna International Group LLP purchased a new stake in Nexalin Technology, Inc. (NASDAQ:NXL) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 62,498 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.35% of Nexalin Technology as of its most recent filing with the SEC. 0.65% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research firms have recently issued reports on NXL. Wall Street Zen lowered shares of Nexalin Technology from a “hold” rating to a “sell” rating in a report on Saturday, November 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Nexalin Technology in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $5.00.

Nexalin Technology Price Performance

Nexalin Technology stock traded up $0.00 during trading hours on Monday, hitting $0.57. The company had a trading volume of 78,404 shares, compared to its average volume of 111,092. Nexalin Technology has a fifty-two week low of $0.54 and a fifty-two week high of $3.87. The firm has a market capitalization of $10.69 million, a P/E ratio of -0.87 and a beta of 3.95. The firm’s fifty day moving average is $0.76 and its 200-day moving average is $0.97.

Nexalin Technology (NASDAQ:NXL) last posted its quarterly earnings results on Friday, November 14th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01). Nexalin Technology had a negative net margin of 5,527.39% and a negative return on equity of 207.46%. The company had revenue of $0.02 million for the quarter, compared to analysts’ expectations of $0.04 million.

Nexalin Technology Company Profile

Nexalin Technology, Inc is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S.